EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
September 30, 2025 -0.0096
June 30, 2025 -0.0171
March 31, 2025 -0.0104
December 31, 2024 0.0218
September 30, 2024 -0.0136
June 30, 2024 -5.235
March 31, 2024 -4.531
December 31, 2023 -0.732
September 30, 2023 -0.0057
June 30, 2023 -0.0066
March 31, 2023 -0.0077
December 31, 2022 -0.0081
September 30, 2022 -0.0094
June 30, 2022 -0.0103
March 31, 2022 -0.0152
December 31, 2021 -0.017
September 30, 2021 -0.0788
June 30, 2021 -0.0339
March 31, 2021 -0.0523
December 31, 2020 -0.0946
Date Value
September 30, 2020 -0.645
June 30, 2020 -0.085
March 31, 2020 -0.745
December 31, 2019 -0.02
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 -0.065
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2010 4.17
September 30, 2010 -2.625
June 30, 2010 -1.04
March 31, 2010 -0.065
December 31, 2009 -0.125
September 30, 2009 -0.075
June 30, 2009 -0.955
March 31, 2009 -0.69

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
BioLineRx Ltd. -0.6957
XTL Biopharmaceuticals Ltd. --
Kamada Ltd. 0.1605
Can-Fite BioPharma Ltd. --
Eocene Ltd. -2.860

EPS Diluted (Quarterly) Related Metrics